U
SMLR

UBS’s Semler Scientific SMLR Stock Holding History

UBS’s Portfolio SMLR Stock Details SMLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$4K Sell
1,547
-394
-20% -$1.41K ﹤0.01% 9638
2014
Q2 		$8K Buy
1,941
+128
+7% +$595 ﹤0.01% 9112
2014
Q1 		$9K Buy
+1,813
New +$11.3K ﹤0.01% 9029

Other funds holding SMLR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GA
Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return
BOS
Bingham Osborn & Scarborough San Francisco, California $1.42B AUM 27.88% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

UBS's SMLR Position: Q3 2014 in Review

UBS reduced its Semler Scientific (SMLR) stake by 20% in Q3 2014, selling an estimated $1.41K and leaving 1,547 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #9638.

UBS first reported a position in SMLR in Q1 2014 and has held it in 3 quarters since. The position peaked at $9K in Q1 2014. 11 funds tracked by Wall St. Rank hold SMLR as of Q3 2014.

  • UBS held 1,547 shares of Semler Scientific worth $4K as of Q3 2014.
  • UBS sold 394 Semler Scientific shares in Q3 2014, an estimated $1.41K.
  • Semler Scientific made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9638 holding.
  • UBS first reported a position in Semler Scientific in Q1 2014 and has held it in 3 quarters since.
  • UBS's Semler Scientific position peaked at $9K in Q1 2014.
  • 11 funds tracked by Wall St. Rank held Semler Scientific as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.